SCHEMBL3437285

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3437297	1.00	MET (0.58)	METCA12CA4CA6CA5A
	SCHEMBL3437296	0.96	MET (0.62)	METCA12CA4CA6CA5A
	SCHEMBL19228913	0.93	MET (0.53)	METCA12CA4CA6CA5A
	SCHEMBL3437320	0.92	CA12 (0.52)	METCA12CA4CA6CA5A
	SCHEMBL16977654	0.92	MET (0.51)	METCA12CA4CA6CA5A
	SCHEMBL3437306	0.91	CA12 (0.51)	METCA12CA4CA6CA5A
	SCHEMBL3437286	0.90	MET (0.50)	METCA12CA4CA6CA5A
	SCHEMBL9607905	0.89	THRB (0.62)	METCA12CA4CA6CA5A
	SCHEMBL3437322	0.89	MET (0.49)	METCA12CA4CA6CA5A
	SCHEMBL21556847	0.89	MET (0.56)	METCA12CA4CA6CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.